ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
GO:0043312,neutrophil degranulation,25/109,465/15232,1.815921403416869e-15,1.378982584441577e-12,1.099689027544513e-12,TYROBP/SERPINB1/TNFRSF1B/GRN/FTL/ADA2/CTSZ/ASAH1/MAN2B1/CTSC/CTSD/CD68/LGALS3/GNS/TMBIM1/FCER1G/CSTB/ITGB2/CTSS/BRI3/CYBB/FUCA1/GM2A/PSAP/PECAM1,25
GO:0002283,neutrophil activation involved in immune response,25/109,468/15232,2.1070337749503546e-15,1.378982584441577e-12,1.099689027544513e-12,TYROBP/SERPINB1/TNFRSF1B/GRN/FTL/ADA2/CTSZ/ASAH1/MAN2B1/CTSC/CTSD/CD68/LGALS3/GNS/TMBIM1/FCER1G/CSTB/ITGB2/CTSS/BRI3/CYBB/FUCA1/GM2A/PSAP/PECAM1,25
GO:0002250,adaptive immune response,23/109,383/15232,2.689651876916321e-15,1.378982584441577e-12,1.099689027544513e-12,CD4/CD74/TNFRSF1B/LAG3/SLA2/CTSC/SASH3/CTSL/CD8A/FCER1G/C1QC/CD3G/TNFSF13/CTSS/C2/CD8B/C1QB/C1QA/LILRB4/HLA-DMA/HLA-E/HLA-DPA1/HLA-DMB,23
GO:0002446,neutrophil mediated immunity,25/109,477/15232,3.27032154555403e-15,1.378982584441577e-12,1.099689027544513e-12,TYROBP/SERPINB1/TNFRSF1B/GRN/FTL/ADA2/CTSZ/ASAH1/MAN2B1/CTSC/CTSD/CD68/LGALS3/GNS/TMBIM1/FCER1G/CSTB/ITGB2/CTSS/BRI3/CYBB/FUCA1/GM2A/PSAP/PECAM1,25
GO:0042119,neutrophil activation,25/109,478/15232,3.4320124052801816e-15,1.378982584441577e-12,1.099689027544513e-12,TYROBP/SERPINB1/TNFRSF1B/GRN/FTL/ADA2/CTSZ/ASAH1/MAN2B1/CTSC/CTSD/CD68/LGALS3/GNS/TMBIM1/FCER1G/CSTB/ITGB2/CTSS/BRI3/CYBB/FUCA1/GM2A/PSAP/PECAM1,25
GO:0036230,granulocyte activation,25/109,485/15232,4.795842485668599e-15,1.6058079256180358e-12,1.2805740812609838e-12,TYROBP/SERPINB1/TNFRSF1B/GRN/FTL/ADA2/CTSZ/ASAH1/MAN2B1/CTSC/CTSD/CD68/LGALS3/GNS/TMBIM1/FCER1G/CSTB/ITGB2/CTSS/BRI3/CYBB/FUCA1/GM2A/PSAP/PECAM1,25
GO:0019882,antigen processing and presentation,18/109,222/15232,2.2802030923224417e-14,6.544182874965408e-12,5.218750536112416e-12,CD74/LAG3/NCF4/LGMN/CTSD/CD68/CTSL/CD8A/FCER1G/CTSS/CYBB/RILP/PSAP/HLA-DMA/HLA-E/IFI30/HLA-DPA1/HLA-DMB,18
GO:0002478,antigen processing and presentation of exogenous peptide antigen,15/109,167/15232,8.773999240139851e-13,2.20337055918012e-10,1.757108795196428e-10,CD74/LAG3/NCF4/LGMN/CTSD/CTSL/FCER1G/CTSS/CYBB/RILP/HLA-DMA/HLA-E/IFI30/HLA-DPA1/HLA-DMB,15
GO:0019884,antigen processing and presentation of exogenous antigen,15/109,175/15232,1.7416462231795798e-12,3.887741402630862e-10,3.1003339785723046e-10,CD74/LAG3/NCF4/LGMN/CTSD/CTSL/FCER1G/CTSS/CYBB/RILP/HLA-DMA/HLA-E/IFI30/HLA-DPA1/HLA-DMB,15
GO:0019886,antigen processing and presentation of exogenous peptide antigen via MHC class II,12/109,92/15232,2.1861562214562652e-12,4.391987848905637e-10,3.5024523884804584e-10,CD74/LAG3/LGMN/CTSD/CTSL/FCER1G/CTSS/RILP/HLA-DMA/IFI30/HLA-DPA1/HLA-DMB,12
GO:0048002,antigen processing and presentation of peptide antigen,15/109,184/15232,3.6165202956307514e-12,6.154019094829969e-10,4.907608950423732e-10,CD74/LAG3/NCF4/LGMN/CTSD/CTSL/FCER1G/CTSS/CYBB/RILP/HLA-DMA/HLA-E/IFI30/HLA-DPA1/HLA-DMB,15
GO:0002495,antigen processing and presentation of peptide antigen via MHC class II,12/109,96/15232,3.675870041710285e-12,6.154019094829969e-10,4.907608950423732e-10,CD74/LAG3/LGMN/CTSD/CTSL/FCER1G/CTSS/RILP/HLA-DMA/IFI30/HLA-DPA1/HLA-DMB,12
GO:0002504,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,12/109,97/15232,4.170087807293051e-12,6.444389542193646e-10,5.13916894145751e-10,CD74/LAG3/LGMN/CTSD/CTSL/FCER1G/CTSS/RILP/HLA-DMA/IFI30/HLA-DPA1/HLA-DMB,12
GO:0002694,regulation of leukocyte activation,20/109,498/15232,3.228593570783166e-10,4.5515005005400575e-8,3.6296579926237025e-8,CD4/TYROBP/CD74/TNFRSF1B/GRN/LAG3/CTSC/SASH3/LGALS3/SLAMF8/FCER1G/ITGB2/TNFSF13/ICOS/LILRB4/AIF1/HLA-E/HLA-DPA1/HLA-DMB/CEBPA,20
GO:0042110,T cell activation,19/109,445/15232,3.398332877456489e-10,4.5515005005400575e-8,3.6296579926237025e-8,CD4/CD74/TNFRSF1B/LAG3/SLA2/SASH3/LGALS3/CTSL/CD8A/FCER1G/CD3G/ICOS/CD8B/LILRB4/PSAP/AIF1/HLA-E/HLA-DPA1/HLA-DMB,19
GO:0002697,regulation of immune effector process,17/109,377/15232,1.4031559012818413e-9,1.761837628547012e-7,1.405002159046686e-7,TYROBP/CD74/TNFRSF1B/GRN/LAG3/SASH3/LGALS3/SLAMF8/FCER1G/C1QC/ITGB2/TNFSF13/C2/C1QB/C1QA/HLA-E/HLA-DMB,17
GO:0002449,lymphocyte mediated immunity,14/109,238/15232,1.517694792987805e-9,1.7935581406544118e-7,1.4302981268900551e-7,CD74/TNFRSF1B/LAG3/SLA2/CTSC/SASH3/CD8A/FCER1G/C1QC/TNFSF13/C2/C1QB/C1QA/HLA-E,14
GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,14/109,246/15232,2.329982564013688e-9,2.5843112592423695e-7,2.0608953061574947e-7,CD4/CD74/TNFRSF1B/SLA2/CTSC/SASH3/CD8A/FCER1G/C1QC/TNFSF13/C2/C1QB/C1QA/HLA-E,14
GO:0030595,leukocyte chemotaxis,13/109,205/15232,2.444097258616477e-9,2.5843112592423695e-7,2.0608953061574947e-7,CD74/LGMN/LGALS3/SLAMF8/FCER1G/ITGB2/CCR5/CCR1/AIF1/GPSM3/CCL4/CCL18/CCL4L2,13
GO:0002548,monocyte chemotaxis,8/109,55/15232,4.88375450446471e-9,4.905731399734801e-7,3.9121443977869944e-7,LGMN/LGALS3/SLAMF8/CCR1/AIF1/CCL4/CCL18/CCL4L2,8
GO:0071674,mononuclear cell migration,9/109,82/15232,6.678871515741191e-9,6.244544923162527e-7,4.979800043516473e-7,LGMN/LGALS3/SLAMF8/CCR1/AIF1/PECAM1/CCL4/CCL18/CCL4L2,9
GO:0002696,positive regulation of leukocyte activation,15/109,315/15232,6.838227392213817e-9,6.244544923162527e-7,4.979800043516473e-7,CD4/TYROBP/CD74/CTSC/SASH3/FCER1G/ITGB2/TNFSF13/ICOS/LILRB4/AIF1/HLA-E/HLA-DPA1/HLA-DMB/CEBPA,15
GO:0050867,positive regulation of cell activation,15/109,328/15232,1.1780153011015224e-8,1.028970756483895e-6,8.205671799892528e-7,CD4/TYROBP/CD74/CTSC/SASH3/FCER1G/ITGB2/TNFSF13/ICOS/LILRB4/AIF1/HLA-E/HLA-DPA1/HLA-DMB/CEBPA,15
GO:0097529,myeloid leukocyte migration,12/109,196/15232,1.5495388595661486e-8,1.2970931536951634e-6,1.034385150991087e-6,CD74/LGMN/LGALS3/SLAMF8/FCER1G/ITGB2/CCR1/AIF1/PECAM1/CCL4/CCL18/CCL4L2,12
GO:0060326,cell chemotaxis,13/109,270/15232,6.567921459608775e-8,5.277981684941611e-6,4.20900061537876e-6,CD74/LGMN/LGALS3/SLAMF8/FCER1G/ITGB2/CCR5/CCR1/AIF1/GPSM3/CCL4/CCL18/CCL4L2,13
GO:1990266,neutrophil migration,9/109,107/15232,7.045942086698293e-8,5.444345250837258e-6,4.341669577309637e-6,CD74/LGALS3/SLAMF8/FCER1G/ITGB2/PECAM1/CCL4/CCL18/CCL4L2,9
GO:0007159,leukocyte cell-cell adhesion,14/109,332/15232,1.030338730147222e-7,7.666483366169514e-6,6.113744823719578e-6,CD4/CD74/LAG3/SELPLG/SASH3/LGALS3/ITGB2/ICOS/LILRB4/AIF1/HLA-E/HLA-DPA1/HLA-DMB/PECAM1,14
GO:0019724,B cell mediated immunity,9/109,113/15232,1.1322146852209729e-7,8.12364036646048e-6,6.478311093632785e-6,CD74/SLA2/FCER1G/C1QC/TNFSF13/C2/C1QB/C1QA/HLA-E,9
GO:0050900,leukocyte migration,15/109,416/15232,2.6596666957083936e-7,1.785940435897121e-5,1.4242232812530024e-5,CD74/LGMN/SELPLG/LGALS3/SLAMF8/FCER1G/ITGB2/CCR5/CCR1/AIF1/GPSM3/PECAM1/CCL4/CCL18/CCL4L2,15
GO:0051249,regulation of lymphocyte activation,15/109,417/15232,2.742703054396044e-7,1.785940435897121e-5,1.4242232812530024e-5,CD4/TYROBP/CD74/TNFRSF1B/LAG3/SASH3/LGALS3/SLAMF8/TNFSF13/ICOS/LILRB4/AIF1/HLA-E/HLA-DPA1/HLA-DMB,15
GO:0042116,macrophage activation,8/109,91/15232,2.755806546182715e-7,1.785940435897121e-5,1.4242232812530024e-5,TYROBP/CD74/GRN/CTSC/ITGB2/C1QA/AIF1/CEBPA,8
GO:0150076,neuroinflammatory response,7/109,64/15232,3.5136188092294376e-7,2.2058938086693562e-5,1.7591209959365803e-5,TYROBP/TNFRSF1B/GRN/CTSC/ITGB2/C1QA/AIF1,7
GO:0002521,leukocyte differentiation,16/109,490/15232,3.9064096205777866e-7,2.378174826588113e-5,1.8965089130843354e-5,CD4/TYROBP/CD74/SNX10/LAG3/SASH3/CTSL/CD8A/SLAMF8/FCER1G/C1QC/CD3G/CCR1/LILRB4/PSAP/CEBPA,16
GO:0097530,granulocyte migration,9/109,133/15232,4.5838717319997906e-7,2.7085289145845822e-5,2.159954419846341e-5,CD74/LGALS3/SLAMF8/FCER1G/ITGB2/PECAM1/CCL4/CCL18/CCL4L2,9
GO:0001774,microglial cell activation,6/109,44/15232,6.61519813831923e-7,3.6916480721898144e-5,2.943956598398207e-5,TYROBP/GRN/CTSC/ITGB2/C1QA/AIF1,6
GO:0002269,leukocyte activation involved in inflammatory response,6/109,44/15232,6.61519813831923e-7,3.6916480721898144e-5,2.943956598398207e-5,TYROBP/GRN/CTSC/ITGB2/C1QA/AIF1,6
GO:0016064,immunoglobulin mediated immune response,8/109,110/15232,1.1875461453379518e-6,6.44805461076742e-5,5.14209170186163e-5,CD74/FCER1G/C1QC/TNFSF13/C2/C1QB/C1QA/HLA-E,8
GO:1903037,regulation of leukocyte cell-cell adhesion,12/109,299/15232,1.5064936424426477e-6,7.964594020177051e-5,6.351477351240193e-5,CD4/CD74/LAG3/SASH3/LGALS3/ITGB2/ICOS/LILRB4/AIF1/HLA-E/HLA-DPA1/HLA-DMB,12
GO:0061900,glial cell activation,6/109,52/15232,1.8213575558017316e-6,9.382326486168407e-5,7.482068016006035e-5,TYROBP/GRN/CTSC/ITGB2/C1QA/AIF1,6
GO:0050670,regulation of lymphocyte proliferation,10/109,203/15232,1.9196767989346055e-6,9.641576722649057e-5,7.688810757838079e-5,CD4/TYROBP/CD74/TNFRSF1B/SASH3/LGALS3/AIF1/HLA-E/HLA-DPA1/HLA-DMB,10
GO:0032944,regulation of mononuclear cell proliferation,10/109,204/15232,2.0066817260946028e-6,9.832740457863554e-5,7.841256963070566e-5,CD4/TYROBP/CD74/TNFRSF1B/SASH3/LGALS3/AIF1/HLA-E/HLA-DPA1/HLA-DMB,10
GO:0050863,regulation of T cell activation,12/109,311/15232,2.2693200076106962e-6,1.0854914036404498e-4,8.656403638053835e-5,CD4/CD74/TNFRSF1B/LAG3/SASH3/LGALS3/ICOS/LILRB4/AIF1/HLA-E/HLA-DPA1/HLA-DMB,12
GO:0006909,phagocytosis,11/109,260/15232,2.5436183205447507e-6,1.18840214092428e-4,9.477079764673465e-5,TYROBP/MARCO/NCF4/FCER1G/ITGB2/CD3G/ARHGAP25/C2/FCGR3A/AIF1/PECAM1,11
GO:0071346,cellular response to interferon-gamma,9/109,169/15232,3.3958427023851135e-6,1.5505109066117485e-4,1.2364766968971634e-4,GBP5/GBP4/AIF1/HLA-E/IFI30/HLA-DPA1/CCL4/CCL18/CCL4L2,9
GO:0030593,neutrophil chemotaxis,7/109,90/15232,3.6283383300326205e-6,1.6198514900078967e-4,1.2917733189028418e-4,CD74/LGALS3/FCER1G/ITGB2/CCL4/CCL18/CCL4L2,7
GO:0070663,regulation of leukocyte proliferation,10/109,219/15232,3.790640520365203e-6,1.6555210446551506e-4,1.3202185061775377e-4,CD4/TYROBP/CD74/TNFRSF1B/SASH3/LGALS3/AIF1/HLA-E/HLA-DPA1/HLA-DMB,10
GO:0051251,positive regulation of lymphocyte activation,11/109,272/15232,3.92834857661622e-6,1.679160061791912e-4,1.3390697723650365e-4,CD4/TYROBP/CD74/SASH3/TNFSF13/ICOS/LILRB4/AIF1/HLA-E/HLA-DPA1/HLA-DMB,11
GO:0050727,regulation of inflammatory response,12/109,329/15232,4.0539045164632975e-6,1.696727952828076e-4,1.3530795337844605e-4,TNFRSF1B/GRN/ACP5/CTSC/APOE/GBP5/PIK3AP1/SLAMF8/FCER1G/HLA-E/GPSM3/CEBPA,12
GO:1903039,positive regulation of leukocyte cell-cell adhesion,10/109,222/15232,4.2786708075618224e-6,1.7542550311003472e-4,1.3989553102275175e-4,CD4/CD74/SASH3/ITGB2/ICOS/LILRB4/AIF1/HLA-E/HLA-DPA1/HLA-DMB,10
GO:0034341,response to interferon-gamma,9/109,189/15232,8.448644407785482e-6,3.3549613865421887e-4,2.675461072708188e-4,GBP5/GBP4/AIF1/HLA-E/IFI30/HLA-DPA1/CCL4/CCL18/CCL4L2,9
GO:0030217,T cell differentiation,10/109,240/15232,8.516825819494855e-6,3.3549613865421887e-4,2.675461072708188e-4,CD4/CD74/LAG3/SASH3/CTSL/CD8A/FCER1G/CD3G/LILRB4/PSAP,10
GO:0002573,myeloid leukocyte differentiation,9/109,190/15232,8.816373676962438e-6,3.4061720609649115e-4,2.7162997441977394e-4,CD4/TYROBP/CD74/SNX10/FCER1G/C1QC/CCR1/LILRB4/CEBPA,9
GO:0002253,activation of immune response,13/109,419/15232,9.136578340744046e-6,3.463280355953734e-4,2.761841556030276e-4,CD4/LCP2/SLA2/LGALS3/FCER1G/C1QC/CD3G/C2/C1QB/C1QA/LILRB4/FCGR3A/HLA-DPA1,13
GO:0046651,lymphocyte proliferation,10/109,252/15232,1.3038180381965459e-5,4.850685997660853e-4,3.868247668879421e-4,CD4/TYROBP/CD74/TNFRSF1B/SASH3/LGALS3/AIF1/HLA-E/HLA-DPA1/HLA-DMB,10
GO:0071677,positive regulation of mononuclear cell migration,4/109,21/15232,1.3519705423386648e-5,4.921807429517286e-4,3.924964453498892e-4,LGMN/LGALS3/CCR1/AIF1,4
GO:0042129,regulation of T cell proliferation,8/109,153/15232,1.3906229785286753e-5,4.921807429517286e-4,3.924964453498892e-4,CD4/TNFRSF1B/SASH3/LGALS3/AIF1/HLA-E/HLA-DPA1/HLA-DMB,8
GO:0032943,mononuclear cell proliferation,10/109,254/15232,1.3964311771154072e-5,4.921807429517286e-4,3.924964453498892e-4,CD4/TYROBP/CD74/TNFRSF1B/SASH3/LGALS3/AIF1/HLA-E/HLA-DPA1/HLA-DMB,10
GO:0050870,positive regulation of T cell activation,9/109,204/15232,1.5595138020689633e-5,5.401833152338876e-4,4.3077677073483886e-4,CD4/CD74/SASH3/ICOS/LILRB4/AIF1/HLA-E/HLA-DPA1/HLA-DMB,9
GO:0071621,granulocyte chemotaxis,7/109,113/15232,1.6391645334493654e-5,5.581494148643686e-4,4.4510408918999717e-4,CD74/LGALS3/FCER1G/ITGB2/CCL4/CCL18/CCL4L2,7
GO:0002688,regulation of leukocyte chemotaxis,7/109,115/15232,1.837950329001348e-5,6.15407035160618e-4,4.90764982585974e-4,CD74/LGMN/SLAMF8/CCR1/AIF1/GPSM3/CCL4,7
GO:0022409,positive regulation of cell-cell adhesion,10/109,265/15232,2.0140030744158535e-5,6.588692360915763e-4,5.254245250747317e-4,CD4/CD74/SASH3/ITGB2/ICOS/LILRB4/AIF1/HLA-E/HLA-DPA1/HLA-DMB,10
GO:0002699,positive regulation of immune effector process,9/109,211/15232,2.0392678578227585e-5,6.588692360915763e-4,5.254245250747317e-4,TYROBP/CD74/LAG3/SASH3/FCER1G/ITGB2/TNFSF13/HLA-E/HLA-DMB,9
GO:0071675,regulation of mononuclear cell migration,5/109,47/15232,2.0661404616112148e-5,6.588692360915763e-4,5.254245250747317e-4,LGMN/LGALS3/SLAMF8/CCR1/AIF1,5
GO:0090025,regulation of monocyte chemotaxis,4/109,24/15232,2.3609642447139108e-5,7.411214324422261e-4,5.910176941537126e-4,LGMN/SLAMF8/CCR1/AIF1,4
GO:0070661,leukocyte proliferation,10/109,277/15232,2.942656746930426e-5,9.09507293012804e-4,7.252993633729731e-4,CD4/TYROBP/CD74/TNFRSF1B/SASH3/LGALS3/AIF1/HLA-E/HLA-DPA1/HLA-DMB,10
GO:0030098,lymphocyte differentiation,11/109,338/15232,3.0150469528497226e-5,9.1776201943562e-4,7.318822108831384e-4,CD4/CD74/LAG3/SASH3/CTSL/CD8A/SLAMF8/FCER1G/CD3G/LILRB4/PSAP,11
GO:0032103,positive regulation of response to external stimulus,13/109,472/15232,3.204985203123746e-5,9.610172049366575e-4,7.663766660101086e-4,CD74/GRN/LAG3/LGMN/CTSC/GBP5/FCER1G/CCR1/AIF1/HLA-E/GPSM3/CEBPA/CCL4,13
GO:0006911,"phagocytosis, engulfment",5/109,52/15232,3.4026574592136e-5,9.921734776547585e-4,7.912226732286512e-4,MARCO/FCER1G/ITGB2/ARHGAP25/AIF1,5
GO:0022407,regulation of cell-cell adhesion,12/109,407/15232,3.407664009864526e-5,9.921734776547585e-4,7.912226732286512e-4,CD4/CD74/LAG3/SASH3/LGALS3/ITGB2/ICOS/LILRB4/AIF1/HLA-E/HLA-DPA1/HLA-DMB,12
GO:0050671,positive regulation of lymphocyte proliferation,7/109,127/15232,3.4942638336049775e-5,0.0010028537202446284,7.997397826686883e-4,CD4/CD74/SASH3/AIF1/HLA-E/HLA-DPA1/HLA-DMB,7
GO:0032946,positive regulation of mononuclear cell proliferation,7/109,128/15232,3.6748535557862395e-5,0.0010398282807851486,8.292256652196675e-4,CD4/CD74/SASH3/AIF1/HLA-E/HLA-DPA1/HLA-DMB,7
GO:0006958,"complement activation, classical pathway",4/109,27/15232,3.8354577905951045e-5,0.0010701992640702175,8.534454323517177e-4,C1QC/C2/C1QB/C1QA,4
GO:0002683,negative regulation of immune system process,12/109,414/15232,4.0222719873089086e-5,0.0011069512907539174,8.827538521534475e-4,TYROBP/CD74/GRN/LAG3/SLA2/CD68/LGALS3/SLAMF8/FCER1G/C1QC/LILRB4/HLA-E,12
GO:0055094,response to lipoprotein particle,4/109,28/15232,4.450119891496548e-5,0.0011649260865594327,9.289866672308596e-4,CD68/APOE/FCER1G/ITGB2,4
GO:0002690,positive regulation of leukocyte chemotaxis,6/109,90/15232,4.470233244097431e-5,0.0011649260865594327,9.289866672308596e-4,CD74/LGMN/CCR1/AIF1/GPSM3/CCL4,6
GO:0050729,positive regulation of inflammatory response,7/109,132/15232,4.475710234952528e-5,0.0011649260865594327,9.289866672308596e-4,GRN/CTSC/GBP5/FCER1G/HLA-E/GPSM3/CEBPA,7
GO:0042098,T cell proliferation,8/109,181/15232,4.657141421831067e-5,0.0011649260865594327,9.289866672308596e-4,CD4/TNFRSF1B/SASH3/LGALS3/AIF1/HLA-E/HLA-DPA1/HLA-DMB,8
GO:0070374,positive regulation of ERK1 and ERK2 cascade,8/109,181/15232,4.657141421831067e-5,0.0011649260865594327,9.289866672308596e-4,CD4/MARCO/CD74/APOE/CCR1/CCL4/CCL18/CCL4L2,8
GO:1901136,carbohydrate derivative catabolic process,8/109,181/15232,4.657141421831067e-5,0.0011649260865594327,9.289866672308596e-4,ADA2/MGAT1/CTSL/GNS/FUCA1/GM2A/PSAP/APOBEC3C,8
GO:0002687,positive regulation of leukocyte migration,7/109,133/15232,4.696814983141566e-5,0.0011649260865594327,9.289866672308596e-4,CD74/LGMN/LGALS3/CCR1/AIF1/GPSM3/CCL4,7
GO:0002705,positive regulation of leukocyte mediated immunity,7/109,133/15232,4.696814983141566e-5,0.0011649260865594327,9.289866672308596e-4,TYROBP/LAG3/SASH3/FCER1G/ITGB2/TNFSF13/HLA-E,7
GO:0042742,defense response to bacterium,8/109,185/15232,5.436574657593086e-5,0.0013319607911103063,0.001062190838107404,CD4/GRN/ACP5/SLAMF8/FCER1G/GBP4/MPEG1/HLA-E,8
GO:0044803,multi-organism membrane organization,3/109,11/15232,5.6411424444042486e-5,0.0013344182306095779,0.0010641505577468641,CD4/CTSL/CCR5,3
GO:0098883,synapse pruning,3/109,11/15232,5.6411424444042486e-5,0.0013344182306095779,0.0010641505577468641,C1QC/C1QB/C1QA,3
GO:0070665,positive regulation of leukocyte proliferation,7/109,137/15232,5.67280216517704e-5,0.0013344182306095779,0.0010641505577468641,CD4/CD74/SASH3/AIF1/HLA-E/HLA-DPA1/HLA-DMB,7
GO:0042102,positive regulation of T cell proliferation,6/109,94/15232,5.7122930727936134e-5,0.0013344182306095779,0.0010641505577468641,CD4/SASH3/AIF1/HLA-E/HLA-DPA1/HLA-DMB,6
GO:0071402,cellular response to lipoprotein particle stimulus,4/109,30/15232,5.8910725073301384e-5,0.0013603637548535918,0.001084841180418206,CD68/APOE/FCER1G/ITGB2,4
GO:0042554,superoxide anion generation,4/109,31/15232,6.72668894736163e-5,0.0015184177635111816,0.001210883569235293,TYROBP/ACP5/ITGB2/CYBB,4
GO:0045730,respiratory burst,4/109,31/15232,6.72668894736163e-5,0.0015184177635111816,0.001210883569235293,GRN/NCF4/SLAMF8/CYBB,4
GO:0099024,plasma membrane invagination,5/109,61/15232,7.401031975217927e-5,0.0016520748042458686,0.001317470253366279,MARCO/FCER1G/ITGB2/ARHGAP25/AIF1,5
GO:0002888,positive regulation of myeloid leukocyte mediated immunity,4/109,32/15232,7.645445324151163e-5,0.0016878790831010644,0.0013460228783525822,TYROBP/FCER1G/ITGB2/HLA-E,4
GO:0006801,superoxide metabolic process,5/109,62/15232,8.004718067919783e-5,0.0017479868041794394,0.001393956624642324,TYROBP/NCF4/ACP5/ITGB2/CYBB,5
GO:0002685,regulation of leukocyte migration,8/109,196/15232,8.159348535267537e-5,0.0017625947534787615,0.0014056059389561055,CD74/LGMN/LGALS3/SLAMF8/CCR1/AIF1/GPSM3/CCL4,8
GO:0071887,leukocyte apoptotic process,6/109,101/15232,8.53887263170512e-5,0.001824956927350594,0.0014553375302861359,CD74/LGALS3/CTSL/FCER1G/CD3G/CCR5,6
GO:0002703,regulation of leukocyte mediated immunity,8/109,198/15232,8.759058702876642e-5,0.0018523104141135974,0.0014771509524408033,TYROBP/TNFRSF1B/LAG3/SASH3/FCER1G/ITGB2/TNFSF13/HLA-E,8
GO:0046466,membrane lipid catabolic process,4/109,34/15232,9.752068011019143e-5,0.0020408233993893187,0.001627483279909116,ASAH1/FUCA1/GM2A/PSAP,4
GO:0019377,glycolipid catabolic process,3/109,14/15232,1.2251342098753076e-4,0.0024920677992470584,0.001987334463573929,FUCA1/GM2A/PSAP,3
GO:0048245,eosinophil chemotaxis,3/109,14/15232,1.2251342098753076e-4,0.0024920677992470584,0.001987334463573929,LGALS3/CCL4/CCL4L2,3
GO:1902105,regulation of leukocyte differentiation,9/109,266/15232,1.2280473475632592e-4,0.0024920677992470584,0.001987334463573929,CD4/TYROBP/CD74/LAG3/SASH3/SLAMF8/C1QC/CCR1/LILRB4,9
GO:0002532,production of molecular mediator involved in inflammatory response,5/109,68/15232,1.2463560165456542e-4,0.002503929237240219,0.001996793533876301,GRN/GBP5/SLAMF8/FCER1G/GPSM3,5
GO:0010324,membrane invagination,5/109,69/15232,1.3361347786475488e-4,0.002657717594359332,0.0021194342189698487,MARCO/FCER1G/ITGB2/ARHGAP25/AIF1,5
GO:0030099,myeloid cell differentiation,11/109,400/15232,1.3646695043238838e-4,0.002672225806403978,0.00213100399640924,CD4/TYROBP/CD74/SNX10/DNASE2/LGALS3/FCER1G/C1QC/CCR1/LILRB4/CEBPA,11
GO:0002761,regulation of myeloid leukocyte differentiation,6/109,110/15232,1.3700311501224974e-4,0.002672225806403978,0.00213100399640924,CD4/TYROBP/CD74/C1QC/CCR1/LILRB4,6
GO:0002455,humoral immune response mediated by circulating immunoglobulin,4/109,41/15232,2.0491303087222004e-4,0.00395836806752202,0.003156656204327115,C1QC/C2/C1QB/C1QA,4
GO:0002718,regulation of cytokine production involved in immune response,5/109,77/15232,2.2449342553428352e-4,0.004191338533133965,0.0033424417738230038,CD74/TNFRSF1B/SASH3/FCER1G/HLA-E,5
GO:0042590,antigen processing and presentation of exogenous peptide antigen via MHC class I,5/109,77/15232,2.2449342553428352e-4,0.004191338533133965,0.0033424417738230038,NCF4/FCER1G/CYBB/HLA-E/IFI30,5
GO:0044764,multi-organism cellular process,3/109,17/15232,2.2531834822223405e-4,0.004191338533133965,0.0033424417738230038,CD4/CTSL/CCR5,3
GO:0090026,positive regulation of monocyte chemotaxis,3/109,17/15232,2.2531834822223405e-4,0.004191338533133965,0.0033424417738230038,LGMN/CCR1/AIF1,3
GO:0070098,chemokine-mediated signaling pathway,5/109,78/15232,2.3851580666493923e-4,0.0043961307852281,0.003505756231231652,CCR5/CCR1/CCL4/CCL18/CCL4L2,5
GO:2000106,regulation of leukocyte apoptotic process,5/109,80/15232,2.685503866780488e-4,0.0048465990249802506,0.0038649884551203483,CD74/LGALS3/FCER1G/CD3G/CCR5,5
GO:0072677,eosinophil migration,3/109,18/15232,2.6897648205842105e-4,0.0048465990249802506,0.0038649884551203483,LGALS3/CCL4/CCL4L2,3
GO:0030449,regulation of complement activation,4/109,44/15232,2.701936738664948e-4,0.0048465990249802506,0.0038649884551203483,C1QC/C2/C1QB/C1QA,4
GO:0046514,ceramide catabolic process,3/109,19/15232,3.1774968251502446e-4,0.0055996413348481065,0.004465512620386586,ASAH1/GM2A/PSAP,3
GO:0150146,cell junction disassembly,3/109,19/15232,3.1774968251502446e-4,0.0055996413348481065,0.004465512620386586,C1QC/C1QB/C1QA,3
GO:1990868,response to chemokine,5/109,86/15232,3.7606198695441426e-4,0.00650561928163713,0.005187997457049442,CCR5/CCR1/CCL4/CCL18/CCL4L2,5
GO:1990869,cellular response to chemokine,5/109,86/15232,3.7606198695441426e-4,0.00650561928163713,0.005187997457049442,CCR5/CCR1/CCL4/CCL18/CCL4L2,5
GO:0045058,T cell selection,4/109,48/15232,3.78873795894248e-4,0.00650561928163713,0.005187997457049442,CD4/CD74/CTSL/CD3G,4
GO:0002700,regulation of production of molecular mediator of immune response,6/109,133/15232,3.8411038042739207e-4,0.006539641985412125,0.005215129339968695,CD74/TNFRSF1B/SASH3/FCER1G/TNFSF13/HLA-E,6
GO:0032928,regulation of superoxide anion generation,3/109,21/15232,4.316079843234863e-4,0.007244118038980871,0.005776923662114635,TYROBP/ACP5/ITGB2,3
GO:0050921,positive regulation of chemotaxis,6/109,136/15232,4.326999326419634e-4,0.007244118038980871,0.005776923662114635,CD74/LGMN/CCR1/AIF1/GPSM3/CCL4,6
GO:0050852,T cell receptor signaling pathway,7/109,191/15232,4.4302876247586043e-4,0.007355742014991766,0.005865939769362851,CD4/LCP2/SLA2/LGALS3/CD3G/LILRB4/HLA-DPA1,7
GO:0030316,osteoclast differentiation,5/109,90/15232,4.6396373341458456e-4,0.007640189675654921,0.006092776550966331,TYROBP/SNX10/FCER1G/CCR1/LILRB4,5
GO:0043030,regulation of macrophage activation,4/109,51/15232,4.7864731821830366e-4,0.007817906197565627,0.0062344990871053335,CD74/GRN/CTSC/CEBPA,4
GO:0002763,positive regulation of myeloid leukocyte differentiation,4/109,52/15232,5.156990468538183e-4,0.008355156331688074,0.0066629367513710664,CD4/TYROBP/CD74/CCR1,4
GO:1901216,positive regulation of neuron death,5/109,93/15232,5.394291228336521e-4,0.008669704862182456,0.006913777894339524,TYROBP/GRN/CTSZ/ITGB2/C1QA,5
GO:0002720,positive regulation of cytokine production involved in immune response,4/109,53/15232,5.547472709905439e-4,0.008804951999935827,0.007021632623668402,CD74/SASH3/FCER1G/HLA-E,4
GO:0070372,regulation of ERK1 and ERK2 cascade,8/109,260/15232,5.566097083085366e-4,0.008804951999935827,0.007021632623668402,CD4/MARCO/CD74/APOE/CCR1/CCL4/CCL18/CCL4L2,8
GO:0002702,positive regulation of production of molecular mediator of immune response,5/109,94/15232,5.665249763227374e-4,0.008857800313109204,0.007063777253177653,CD74/SASH3/FCER1G/TNFSF13/HLA-E,5
GO:0050860,negative regulation of T cell receptor signaling pathway,3/109,23/15232,5.687686612200534e-4,0.008857800313109204,0.007063777253177653,SLA2/LGALS3/LILRB4,3
GO:0002706,regulation of lymphocyte mediated immunity,6/109,144/15232,5.859509464967789e-4,0.008986072148946783,0.007166069430036943,TNFRSF1B/LAG3/SASH3/FCER1G/TNFSF13/HLA-E,6
GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,6/109,144/15232,5.859509464967789e-4,0.008986072148946783,0.007166069430036943,CD4/TNFRSF1B/SASH3/FCER1G/TNFSF13/HLA-E,6
GO:0002886,regulation of myeloid leukocyte mediated immunity,4/109,54/15232,5.958520675170087e-4,0.00906868790637629,0.007231952526003887,TYROBP/FCER1G/ITGB2/HLA-E,4
GO:0002474,antigen processing and presentation of peptide antigen via MHC class I,5/109,96/15232,6.237701772081962e-4,0.009422212676776436,0.007513875818843487,NCF4/FCER1G/CYBB/HLA-E/IFI30,5
GO:0001819,positive regulation of cytokine production,10/109,404/15232,6.356352711179402e-4,0.009451950446747171,0.0075375906211255644,CD4/TYROBP/CD74/SASH3/GBP5/FCER1G/AIF1/HLA-E/GPSM3/HLA-DPA1,10
GO:0006956,complement activation,4/109,55/15232,6.390737070602399e-4,0.009451950446747171,0.0075375906211255644,C1QC/C2/C1QB/C1QA,4
GO:0002407,dendritic cell chemotaxis,3/109,24/15232,6.466485210447558e-4,0.009451950446747171,0.0075375906211255644,SLAMF8/CCR5/CCR1,3
GO:0032753,positive regulation of interleukin-4 production,3/109,24/15232,6.466485210447558e-4,0.009451950446747171,0.0075375906211255644,SASH3/FCER1G/HLA-E,3
GO:1902107,positive regulation of leukocyte differentiation,6/109,147/15232,6.531924645128193e-4,0.009451950446747171,0.0075375906211255644,CD4/TYROBP/CD74/SASH3/CCR1/LILRB4,6
GO:0002367,cytokine production involved in immune response,5/109,97/15232,6.539677013926614e-4,0.009451950446747171,0.0075375906211255644,CD74/TNFRSF1B/SASH3/FCER1G/HLA-E,5
GO:0071356,cellular response to tumor necrosis factor,8/109,267/15232,6.625976248934899e-4,0.00950827591722158,0.007582508158555577,TNFRSF1B/RFFL/ASAH1/TNFSF13/CEBPA/CCL4/CCL18/CCL4L2,8
GO:0002456,T cell mediated immunity,5/109,98/15232,6.852476170219767e-4,0.009702265681092857,0.007737208020027419,TNFRSF1B/CTSC/SASH3/CD8A/HLA-E,5
GO:0045785,positive regulation of cell adhesion,10/109,408/15232,6.857748764137311e-4,0.009702265681092857,0.007737208020027419,CD4/CD74/SASH3/ITGB2/ICOS/LILRB4/AIF1/HLA-E/HLA-DPA1/HLA-DMB,10
GO:0050920,regulation of chemotaxis,7/109,207/15232,7.149617792542973e-4,0.010044463038614568,0.008010098108391909,CD74/LGMN/SLAMF8/CCR1/AIF1/GPSM3/CCL4,7
GO:0002824,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,5/109,100/15232,7.511530779619604e-4,0.010479628705733183,0.008357127080834092,CD4/SASH3/FCER1G/TNFSF13/HLA-E,5
GO:0002708,positive regulation of lymphocyte mediated immunity,5/109,102/15232,8.216852758687359e-4,0.011279540044229567,0.008995027611179903,LAG3/SASH3/FCER1G/TNFSF13/HLA-E,5
GO:0002429,immune response-activating cell surface receptor signaling pathway,9/109,345/15232,8.25332198358261e-4,0.011279540044229567,0.008995027611179903,CD4/LCP2/SLA2/LGALS3/FCER1G/CD3G/LILRB4/FCGR3A/HLA-DPA1,9
GO:0002757,immune response-activating signal transduction,9/109,345/15232,8.25332198358261e-4,0.011279540044229567,0.008995027611179903,CD4/LCP2/SLA2/LGALS3/FCER1G/CD3G/LILRB4/FCGR3A/HLA-DPA1,9
GO:0070371,ERK1 and ERK2 cascade,8/109,278/15232,8.616049992260261e-4,0.011695705698953287,0.009326904756913314,CD4/MARCO/CD74/APOE/CCR1/CCL4/CCL18/CCL4L2,8
GO:0002920,regulation of humoral immune response,4/109,60/15232,8.890544065681685e-4,0.011987317468425842,0.009559454657695178,C1QC/C2/C1QB/C1QA,4
GO:0002821,positive regulation of adaptive immune response,5/109,105/15232,9.366002029041563e-4,0.01246112455387053,0.009937298771837756,CD4/SASH3/FCER1G/TNFSF13/HLA-E,5
GO:0006664,glycolipid metabolic process,5/109,105/15232,9.366002029041563e-4,0.01246112455387053,0.009937298771837756,ASAH1/ST8SIA4/FUCA1/GM2A/PSAP,5
GO:1903509,liposaccharide metabolic process,5/109,106/15232,9.774385003096524e-4,0.012918907546855866,0.010302364248416143,ASAH1/ST8SIA4/FUCA1/GM2A/PSAP,5
GO:0002819,regulation of adaptive immune response,6/109,159/15232,9.839703987528639e-4,0.012920238765323552,0.01030342584727801,CD4/TNFRSF1B/SASH3/FCER1G/TNFSF13/HLA-E,6
GO:0006687,glycosphingolipid metabolic process,4/109,63/15232,0.001068329828420818,0.013936848216217036,0.011114135330529634,ASAH1/ST8SIA4/GM2A/PSAP,4
GO:0034612,response to tumor necrosis factor,8/109,288/15232,0.0010818111458506773,0.014021668335574262,0.011181776325872536,TNFRSF1B/RFFL/ASAH1/TNFSF13/CEBPA/CCL4/CCL18/CCL4L2,8
GO:0051928,positive regulation of calcium ion transport,5/109,109/15232,0.0011079159389333802,0.014267968726392055,0.011378192031421085,CD4/LGALS3/CCR1/TRPV2/CCL4,5
GO:0036336,dendritic cell migration,3/109,29/15232,0.001137470820282997,0.014555279477379241,0.011607312024610936,SLAMF8/CCR5/CCR1,3
GO:0030149,sphingolipid catabolic process,3/109,30/15232,0.0012573108308618554,0.015689052541624022,0.012511455276703132,ASAH1/GM2A/PSAP,3
GO:0032673,regulation of interleukin-4 production,3/109,30/15232,0.0012573108308618554,0.015689052541624022,0.012511455276703132,SASH3/FCER1G/HLA-E,3
GO:0033028,myeloid cell apoptotic process,3/109,30/15232,0.0012573108308618554,0.015689052541624022,0.012511455276703132,CTSL/FCER1G/CCR5,3
GO:0050858,negative regulation of antigen receptor-mediated signaling pathway,3/109,30/15232,0.0012573108308618554,0.015689052541624022,0.012511455276703132,SLA2/LGALS3/LILRB4,3
GO:1901214,regulation of neuron death,8/109,299/15232,0.0013738576260210779,0.017037530683187318,0.013586818107888763,TYROBP/TNFRSF1B/GRN/LGMN/CTSZ/APOE/ITGB2/C1QA,8
GO:0150077,regulation of neuroinflammatory response,3/109,31/15232,0.001384815538867737,0.017068063911566157,0.013611167259649315,TNFRSF1B/GRN/CTSC,3
GO:0050851,antigen receptor-mediated signaling pathway,7/109,235/15232,0.0014947801229075767,0.01820438002821017,0.014517338504590332,CD4/LCP2/SLA2/LGALS3/CD3G/LILRB4/HLA-DPA1,7
GO:0050830,defense response to Gram-positive bacterium,4/109,69/15232,0.0015004487616153543,0.01820438002821017,0.014517338504590332,ACP5/GBP4/MPEG1/HLA-E,4
GO:0002768,immune response-regulating cell surface receptor signaling pathway,9/109,376/15232,0.001504194666342901,0.01820438002821017,0.014517338504590332,CD4/LCP2/SLA2/LGALS3/FCER1G/CD3G/LILRB4/FCGR3A/HLA-DPA1,9
GO:0050864,regulation of B cell activation,5/109,118/15232,0.0015771980535357812,0.01897359814103823,0.015130762291090194,TYROBP/CD74/SASH3/SLAMF8/TNFSF13,5
GO:0002764,immune response-regulating signaling pathway,9/109,379/15232,0.0015886081995872792,0.018997106386731216,0.01514950927175338,CD4/LCP2/SLA2/LGALS3/FCER1G/CD3G/LILRB4/FCGR3A/HLA-DPA1,9
GO:0032633,interleukin-4 production,3/109,33/15232,0.0016635273188794677,0.019658978727228535,0.015677328664610215,SASH3/FCER1G/HLA-E,3
GO:0090322,regulation of superoxide metabolic process,3/109,33/15232,0.0016635273188794677,0.019658978727228535,0.015677328664610215,TYROBP/ACP5/ITGB2,3
GO:1903706,regulation of hemopoiesis,10/109,464/15232,0.0018053230859056205,0.021077967537638808,0.016808921218876248,CD4/TYROBP/CD74/LAG3/SASH3/LGALS3/SLAMF8/C1QC/CCR1/LILRB4,10
GO:0045637,regulation of myeloid cell differentiation,7/109,243/15232,0.0018090860206639067,0.021077967537638808,0.016808921218876248,CD4/TYROBP/CD74/LGALS3/C1QC/CCR1/LILRB4,7
GO:0097242,amyloid-beta clearance,3/109,34/15232,0.0018150763484377868,0.021077967537638808,0.016808921218876248,MARCO/APOE/ITGB2,3
GO:0043368,positive T cell selection,3/109,35/15232,0.0019749741360562223,0.022803005973200865,0.018184577344691897,CD74/CTSL/CD3G,3
GO:0050728,negative regulation of inflammatory response,5/109,127/15232,0.0021785922934598172,0.02468448372852739,0.019684988202991114,TNFRSF1B/GRN/ACP5/APOE/SLAMF8,5
GO:0002291,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,2/109,10/15232,0.002199364155005676,0.02468448372852739,0.019684988202991114,LGALS3/HLA-DMB,2
GO:0002524,hypersensitivity,2/109,10/15232,0.002199364155005676,0.02468448372852739,0.019684988202991114,FCER1G/HLA-E,2
GO:0046598,positive regulation of viral entry into host cell,2/109,10/15232,0.002199364155005676,0.02468448372852739,0.019684988202991114,CD4/CD74,2
GO:0075294,positive regulation by symbiont of entry into host,2/109,10/15232,0.002199364155005676,0.02468448372852739,0.019684988202991114,CD4/CD74,2
GO:0050866,negative regulation of cell activation,6/109,187/15232,0.0022497305149309353,0.024938937788438652,0.019887906166463354,TYROBP/CD74/GRN/LAG3/APOE/LGALS3,6
GO:0046718,viral entry into host cell,5/109,128/15232,0.002254440995034936,0.024938937788438652,0.019887906166463354,CD4/CD74/SELPLG/CTSL/CCR5,5
GO:0006898,receptor-mediated endocytosis,7/109,253/15232,0.002271690201734332,0.024938937788438652,0.019887906166463354,MARCO/APOE/APOC1/CTSL/FCER1G/ITGB2/CD163,7
GO:0043270,positive regulation of ion transport,7/109,253/15232,0.002271690201734332,0.024938937788438652,0.019887906166463354,CD4/APOE/LGALS3/CTSS/CCR1/TRPV2/CCL4,7
GO:0032755,positive regulation of interleukin-6 production,4/109,78/15232,0.0023570323072152908,0.025735206006497386,0.020522901439254424,TYROBP/CD74/FCER1G/AIF1,4
GO:1903708,positive regulation of hemopoiesis,6/109,189/15232,0.0023727397232536167,0.02576667083252171,0.02054799350664014,CD4/TYROBP/CD74/SASH3/CCR1/LILRB4,6
GO:0002714,positive regulation of B cell mediated immunity,3/109,38/15232,0.002506328316184911,0.026783050995827052,0.02135852014128463,FCER1G/TNFSF13/HLA-E,3
GO:0002891,positive regulation of immunoglobulin mediated immune response,3/109,38/15232,0.002506328316184911,0.026783050995827052,0.02135852014128463,FCER1G/TNFSF13/HLA-E,3
GO:1901658,glycosyl compound catabolic process,3/109,38/15232,0.002506328316184911,0.026783050995827052,0.02135852014128463,ADA2/FUCA1/APOBEC3C,3
GO:0031348,negative regulation of defense response,6/109,193/15232,0.002633900219681458,0.02785094263560985,0.02221012532624149,TNFRSF1B/GRN/ACP5/APOE/SLAMF8/HLA-E,6
GO:0002604,regulation of dendritic cell antigen processing and presentation,2/109,11/15232,0.0026755758729082634,0.02785094263560985,0.02221012532624149,CD74/CD68,2
GO:0009313,oligosaccharide catabolic process,2/109,11/15232,0.0026755758729082634,0.02785094263560985,0.02221012532624149,MAN2B1/GM2A,2
GO:0045657,positive regulation of monocyte differentiation,2/109,11/15232,0.0026755758729082634,0.02785094263560985,0.02221012532624149,CD4/CD74,2
GO:0071888,macrophage apoptotic process,2/109,11/15232,0.0026755758729082634,0.02785094263560985,0.02221012532624149,CTSL/CCR5,2
GO:0032611,interleukin-1 beta production,4/109,82/15232,0.0028278076208616133,0.029283842836654545,0.023352811714331935,TYROBP/SERPINB1/ACP5/GBP5,4
GO:0070997,neuron death,8/109,336/15232,0.0028424754488207077,0.02928478552144001,0.02335356347155259,TYROBP/TNFRSF1B/GRN/LGMN/CTSZ/APOE/ITGB2/C1QA,8
GO:0002440,production of molecular mediator of immune response,6/109,197/15232,0.0029161047824827996,0.029890074020448694,0.02383625928538572,CD74/TNFRSF1B/SASH3/FCER1G/TNFSF13/HLA-E,6
GO:0031349,positive regulation of defense response,8/109,340/15232,0.0030554777271087053,0.031159668800819232,0.024848715472398874,GRN/LAG3/CTSC/GBP5/FCER1G/HLA-E/GPSM3/CEBPA,8
GO:0030225,macrophage differentiation,3/109,41/15232,0.0031182768359597126,0.03147163834170535,0.02509749996388648,CD4/C1QC/CEBPA,3
GO:0002468,dendritic cell antigen processing and presentation,2/109,12/15232,0.0031957263423135346,0.03147163834170535,0.02509749996388648,CD74/CD68,2
GO:0002679,respiratory burst involved in defense response,2/109,12/15232,0.0031957263423135346,0.03147163834170535,0.02509749996388648,GRN/SLAMF8,2
GO:0002863,positive regulation of inflammatory response to antigenic stimulus,2/109,12/15232,0.0031957263423135346,0.03147163834170535,0.02509749996388648,FCER1G/HLA-E,2
GO:0150079,negative regulation of neuroinflammatory response,2/109,12/15232,0.0031957263423135346,0.03147163834170535,0.02509749996388648,TNFRSF1B/GRN,2
GO:1900272,negative regulation of long-term synaptic potentiation,2/109,12/15232,0.0031957263423135346,0.03147163834170535,0.02509749996388648,TYROBP/APOE,2
GO:1902563,regulation of neutrophil activation,2/109,12/15232,0.0031957263423135346,0.03147163834170535,0.02509749996388648,GRN/ITGB2,2
GO:0002639,positive regulation of immunoglobulin production,3/109,42/15232,0.003340817981272198,0.03274001621646754,0.026108985712432784,SASH3/TNFSF13/HLA-E,3
GO:0002224,toll-like receptor signaling pathway,5/109,141/15232,0.0034242899941775012,0.033233809653635746,0.026502768223433292,LGMN/CTSL/PIK3AP1/ITGB2/CTSS,5
GO:0044409,entry into host,5/109,141/15232,0.0034242899941775012,0.033233809653635746,0.026502768223433292,CD4/CD74/SELPLG/CTSL/CCR5,5
GO:0050856,regulation of T cell receptor signaling pathway,3/109,43/15232,0.00357285558283165,0.03450897531686916,0.02751966698921949,SLA2/LGALS3/LILRB4,3
GO:0002286,T cell activation involved in immune response,4/109,88/15232,0.003648889782865206,0.03496379900997564,0.02788237253055091,CD74/LGALS3/FCER1G/HLA-DMB,4
GO:0006596,polyamine biosynthetic process,2/109,13/15232,0.0037591740100322247,0.03496379900997564,0.02788237253055091,OAZ1/SAT1,2
GO:0033033,negative regulation of myeloid cell apoptotic process,2/109,13/15232,0.0037591740100322247,0.03496379900997564,0.02788237253055091,FCER1G/CCR5,2
GO:0034433,steroid esterification,2/109,13/15232,0.0037591740100322247,0.03496379900997564,0.02788237253055091,APOE/APOC1,2
GO:0034434,sterol esterification,2/109,13/15232,0.0037591740100322247,0.03496379900997564,0.02788237253055091,APOE/APOC1,2
GO:0034435,cholesterol esterification,2/109,13/15232,0.0037591740100322247,0.03496379900997564,0.02788237253055091,APOE/APOC1,2
GO:0045059,positive thymic T cell selection,2/109,13/15232,0.0037591740100322247,0.03496379900997564,0.02788237253055091,CD74/CD3G,2
GO:0046479,glycosphingolipid catabolic process,2/109,13/15232,0.0037591740100322247,0.03496379900997564,0.02788237253055091,GM2A/PSAP,2
GO:0030574,collagen catabolic process,3/109,44/15232,0.0038145137712925184,0.03515301911250766,0.028033268758605567,CTSD/CTSL/CTSS,3
GO:1900271,regulation of long-term synaptic potentiation,3/109,44/15232,0.0038145137712925184,0.03515301911250766,0.028033268758605567,TYROBP/LGMN/APOE,3
GO:1902106,negative regulation of leukocyte differentiation,4/109,91/15232,0.004114418398610876,0.03774368293520205,0.03009923000569937,CD74/LAG3/C1QC/LILRB4,4
GO:0032612,interleukin-1 production,4/109,92/15232,0.004278104720523588,0.03889010128294972,0.03101345741670351,TYROBP/SERPINB1/ACP5/GBP5,4
GO:0045639,positive regulation of myeloid cell differentiation,4/109,92/15232,0.004278104720523588,0.03889010128294972,0.03101345741670351,CD4/TYROBP/CD74/CCR1,4
GO:2000107,negative regulation of leukocyte apoptotic process,3/109,46/15232,0.004327168107511066,0.039151141845475544,0.03122162787918251,CD74/FCER1G/CCR5,3
GO:0002864,regulation of acute inflammatory response to antigenic stimulus,2/109,14/15232,0.0043652841082063324,0.039151141845475544,0.03122162787918251,FCER1G/HLA-E,2
GO:0060263,regulation of respiratory burst,2/109,14/15232,0.0043652841082063324,0.039151141845475544,0.03122162787918251,GRN/SLAMF8,2
GO:0045088,regulation of innate immune response,7/109,285/15232,0.004384818901771557,0.039151560771818035,0.031221961957877478,GRN/LAG3/APOE/GBP5/SLAMF8/FCER1G/HLA-E,7
GO:0032760,positive regulation of tumor necrosis factor production,3/109,47/15232,0.004598392381915818,0.04069678544171312,0.03245422307106828,SASH3/FCER1G/HLA-E,3
GO:0034656,nucleobase-containing small molecule catabolic process,3/109,47/15232,0.004598392381915818,0.04069678544171312,0.03245422307106828,ADA2/MGAT1/APOBEC3C,3
GO:0016125,sterol metabolic process,5/109,152/15232,0.004711725142001441,0.04151691144860042,0.033108244072604764,LIPA/APOE/APOC1/FDX1/CEBPA,5
GO:0009311,oligosaccharide metabolic process,3/109,48/15232,0.004879693620983921,0.042497797638547524,0.03389046553973925,MAN2B1/ST8SIA4/GM2A,3
GO:0034381,plasma lipoprotein particle clearance,3/109,48/15232,0.004879693620983921,0.042497797638547524,0.03389046553973925,LIPA/APOE/APOC1,3
GO:0045732,positive regulation of protein catabolic process,6/109,219/15232,0.004891135324837676,0.042497797638547524,0.03389046553973925,TNFRSF1B/OAZ1/CTSC/APOE/RILP/CEBPA,6
GO:0006672,ceramide metabolic process,4/109,96/15232,0.004976815187265936,0.042497797638547524,0.03389046553973925,ASAH1/ST8SIA4/GM2A/PSAP,4
GO:0002281,macrophage activation involved in immune response,2/109,15/15232,0.005013428591506104,0.042497797638547524,0.03389046553973925,TYROBP/GRN,2
GO:0002523,leukocyte migration involved in inflammatory response,2/109,15/15232,0.005013428591506104,0.042497797638547524,0.03389046553973925,SLAMF8/ITGB2,2
GO:0034375,high-density lipoprotein particle remodeling,2/109,15/15232,0.005013428591506104,0.042497797638547524,0.03389046553973925,APOE/APOC1,2
GO:0042159,lipoprotein catabolic process,2/109,15/15232,0.005013428591506104,0.042497797638547524,0.03389046553973925,CTSD/APOE,2
GO:0051044,positive regulation of membrane protein ectodomain proteolysis,2/109,15/15232,0.005013428591506104,0.042497797638547524,0.03389046553973925,TNFRSF1B/APOE,2
GO:0002437,inflammatory response to antigenic stimulus,3/109,49/15232,0.00517117619412743,0.04346817143933893,0.034664303754511995,CD68/FCER1G/HLA-E,3
GO:1903557,positive regulation of tumor necrosis factor superfamily cytokine production,3/109,49/15232,0.00517117619412743,0.04346817143933893,0.034664303754511995,SASH3/FCER1G/HLA-E,3
GO:0008202,steroid metabolic process,7/109,295/15232,0.005281418438483934,0.044209873512142596,0.035255784488476084,LGMN/ASAH1/LIPA/APOE/APOC1/FDX1/CEBPA,7
GO:0035821,modulation of process of other organism,4/109,98/15232,0.00535327587710729,0.04462544081787778,0.03558718447240575,CD4/APOE/MPEG1/CCL4,4
GO:0031638,zymogen activation,3/109,50/15232,0.005472940702597775,0.04524748095275279,0.036083239113510135,LGMN/CTSZ/CTSL,3
GO:0043277,apoptotic cell clearance,3/109,50/15232,0.005472940702597775,0.04524748095275279,0.036083239113510135,TYROBP/MARCO/C2,3
GO:0001909,leukocyte mediated cytotoxicity,4/109,99/15232,0.005548460777528984,0.045683843041212,0.03643122218895217,TYROBP/LAG3/CTSC/HLA-E,4
GO:0006595,polyamine metabolic process,2/109,16/15232,0.005702986074865383,0.04648893533838028,0.03707325434754907,OAZ1/SAT1,2
GO:0097067,cellular response to thyroid hormone stimulus,2/109,16/15232,0.005702986074865383,0.04648893533838028,0.03707325434754907,CTSL/CTSS,2
GO:0032680,regulation of tumor necrosis factor production,4/109,100/15232,0.005748348598344279,0.04648893533838028,0.03707325434754907,ACP5/SASH3/FCER1G/HLA-E,4
GO:0001912,positive regulation of leukocyte mediated cytotoxicity,3/109,51/15232,0.005785084039121488,0.04648893533838028,0.03707325434754907,TYROBP/LAG3/HLA-E,3
GO:0032623,interleukin-2 production,3/109,51/15232,0.005785084039121488,0.04648893533838028,0.03707325434754907,CD4/SASH3/FCER1G,3
GO:0070228,regulation of lymphocyte apoptotic process,3/109,51/15232,0.005785084039121488,0.04648893533838028,0.03707325434754907,CD74/LGALS3/CD3G,3
GO:0032653,regulation of interleukin-10 production,3/109,52/15232,0.006107699446811345,0.04888592903842229,0.03898477063554988,TYROBP/SASH3/FCER1G,3
GO:0052126,movement in host environment,5/109,162/15232,0.006152042793899586,0.049045452273588364,0.03911198467967907,CD4/CD74/SELPLG/CTSL/CCR5,5
